Patent Application for Treating DNAse1 Deficiency Diseases
Summary
The USPTO has published a new patent application (US20260083828A1) detailing compositions and methods for treating diseases associated with DNAse1 and/or DNAse1L3 deficiency. The application was filed on September 11, 2025, by inventors Demetrios Braddock, Paul Stabach, and Ethan Lester.
What changed
This document is a publication of a new patent application filed with the USPTO, specifically application number US20260083828A1. The application, filed on September 11, 2025, by inventors Demetrios Braddock, Paul Stabach, and Ethan Lester, describes "Compositions and Methods for Treating, Ameliorating, and/or Preventing Diseases and/or Disorders" related to DNAse1 and/or DNAse1L3 deficiency.
As this is a patent application, it does not impose immediate regulatory obligations or compliance deadlines on entities. However, it signifies potential future intellectual property rights and may inform research and development strategies in the biotechnology and pharmaceutical sectors. Companies operating in these areas should monitor the progress of this and similar patent applications to understand emerging therapeutic approaches and potential patent landscapes.
Archived snapshot
Mar 27, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
COMPOSITIONS AND METHODS FOR TREATING, AMELIORATING, AND/OR PREVENTING DISEASES AND/OR DISORDERS
Application US20260083828A1 Kind: A1 Mar 26, 2026
Inventors
Demetrios Braddock, Paul Stabach, Ethan Lester
Abstract
The present disclosure includes compositions and methods for treating, ameliorating, and/or preventing certain diseases and/or disorders associated with associated with DNAse1 and/or DNAse1L3 deficiency.
CPC Classifications
A61K 38/465 C12N 9/22 C12Y 301/21001 C07K 2319/30
Filing Date
2025-09-11
Application No.
19326001
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Biotech (C12N) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.